Showing results (41-50 of 268) with videos related to
Sort By:
Pageof 27
Biochemical and Biophysical Research Communications|July 31, 1986
Frameshift mutagenesis in Salmonella typhimurium by reversible DNA intercalators: effect of a UVR B mutationB René, C Auclair, C PaolettiBiochimie|August 1, 1982
Measurement of recA protein induction in Salmonella typhimurium: a possible biochemical test for the detection of DNA damaging agentsA Pierre, B Salles, C PaolettiBiochemical Pharmacology|June 15, 1982
Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiaeM Pinto, M Guerineau, C PaolettiJournal of Chromatography. A|June 30, 1995
Purification of preparative quantities of group B Streptococcus type III oligosaccharidesL C Paoletti, K D JohnsonExpert Opinion on Biological Therapy|August 29, 2003
Glycoconjugate vaccines to prevent group B streptococcal infectionsLawrence C Paoletti, Dennis L KasperMutation Research|May 1, 1988
Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coliB René, C Auclair, C PaolettiSeminars in Neonatology : SN|October 29, 2002
Vaccines to prevent neonatal GBS infectionLawrence C Paoletti, Lawrence C MadoffMutation Research|November 1, 1975
Ethidium bromide mutagenesis in yeast: protection by anaerobiosisM Pinto, M Guerineau, C PaolettiBiochemical and Biophysical Research Communications|October 30, 1984
Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitroB Dugue, C Paoletti, B MeunierThe Journal of Infectious Diseases|June 29, 2002
Conjugate vaccines against group B Streptococcus types IV and VIILawrence C Paoletti, Dennis L KasperPageof 27